Shopping Cart
Remove All
Your shopping cart is currently empty
CP-409092 is a partial GABAA receptor agonist. It has anti-anxiety activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,820 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $2,380 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $3,100 | 8-10 weeks | 8-10 weeks |
| Description | CP-409092 is a partial GABAA receptor agonist. It has anti-anxiety activity. |
| In vivo | [14C]CP-409,092(P.O.; 100 mg/kg; ) treatment, the total recovery is 89.1%+ or -3.2% for male rats and 89.3%+ or -0.58% for female rats. The pharmacokinetics of CP-409,092 (P.O.; 4 and 15 mg/kg;single intravenous) treatment , are characterized by high clearance of 169+ or -18 mL/min/kg, a volume of distribution of 8.99+ or -1.46 L/kg, and an oral bioavailability of 2.9%+ or -3%. |
| Molecular Weight | 297.35 |
| Formula | C17H19N3O2 |
| Cas No. | 194098-25-4 |
| Relative Density. | 1.283 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 41.67 mg/mL (140.14 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2 mg/mL (6.73 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.